Johnson Fistel, LLP is investigating 10x Genomics, Inc. for potential securities law violations. Shareholders who have incurred losses on their investment in the Company are encouraged to contact.
01.02.2024 - Johnson Fistel, LLP is investigating 10x Genomics, Inc. (NASDAQ: TXG) (“10x Genomics” or the “Company”) for potential securities law violations. Shareholders who have incurred losses on their investment in the Company are encouraged to contact the .